Andrew C. Jackson, Corporate Controller, Principal Accounting Officer at Eiger Biopharmaceuticals, holds 21.68K shares in Catheter Precision (Ticker: VTAK), holds 1.59K shares in Eiger Biopharmaceuticals (Ticker: EIGRQ), holds ― shares in Eterna Therapeutics (Ticker: ERNA).